The Complement C5a-C5aR1 GPCR Axis in COVID-19 Therapeutics.
Trends Immunol
; 41(11): 965-967, 2020 11.
Article
in English
| MEDLINE | ID: covidwho-834446
ABSTRACT
The current pandemic of coronavirus disease (COVID-19) caused by SARS-CoV-2 is a significant global health challenge. A recent study by Carvelli and colleagues now demonstrates the involvement of complement C5a and its receptor C5aR1 in disease progression and suggests that blockade of the C5a-C5aR1 axis may represent a potential therapeutic strategy against COVID-19.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Complement C5a
/
Coronavirus Infections
/
Receptor, Anaphylatoxin C5a
/
Betacoronavirus
Limits:
Animals
/
Humans
Language:
English
Journal:
Trends Immunol
Journal subject:
Allergy and Immunology
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS